This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Mina Hassan-Zahraee: Innovator in MAdCAM Antagonist Treatments
Introduction
Mina Hassan-Zahraee is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of medical treatments, particularly in the area of MAdCAM antagonists. With a total of 2 patents, her work is paving the way for advancements in patient care.
Latest Patents
Mina's latest patents focus on dosage regimens for MAdCAM antagonists. The first patent provides a method for treating patients by administering an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Additionally, biomarkers for assessing a patient's response to anti-MAdCAM treatment are included in this invention. This innovative approach aims to enhance the effectiveness of treatments for patients.
Career Highlights
Mina is currently associated with Pfizer Corporation, where she continues to develop groundbreaking medical solutions. Her expertise and dedication to research have positioned her as a key player in her field.
Collaborations
Mina has worked alongside notable colleagues such as Fabio Cataldi and Robert A Clare, contributing to a collaborative environment that fosters innovation and progress.
Conclusion
Mina Hassan-Zahraee's contributions to the field of MAdCAM antagonists demonstrate her commitment to improving patient outcomes through innovative treatments. Her work is a testament to the impact of dedicated inventors in the medical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile